Your browser doesn't support javascript.
loading
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03).
Gnant, Michael; Dueck, Amylou C; Frantal, Sophie; Martin, Miguel; Burstein, Hal J; Greil, Richard; Fox, Peter; Wolff, Antonio C; Chan, Arlene; Winer, Eric P; Pfeiler, Georg; Miller, Kathy D; Colleoni, Marco; Suga, Jennifer M; Rubovsky, Gabor; Bliss, Judith M; Mayer, Ingrid A; Singer, Christian F; Nowecki, Zbigniew; Hahn, Olwen; Thomson, Jacqui; Wolmark, Norman; Amillano, Kepa; Rugo, Hope S; Steger, Guenther G; Hernando Fernández de Aránguiz, Blanca; Haddad, Tufia C; Perelló, Antonia; Bellet, Meritxell; Fohler, Hannes; Metzger Filho, Otto; Jallitsch-Halper, Anita; Solomon, Kadine; Schurmans, Céline; Theall, Kathy P; Lu, Dongrui R; Tenner, Kathleen; Fesl, Christian; DeMichele, Angela; Mayer, Erica L.
Afiliación
  • Gnant M; Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria.
  • Dueck AC; ABCSG, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria.
  • Frantal S; Alliance Statistics and Data Center and Mayo Clinic, Phoenix, AZ.
  • Martin M; ABCSG, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria.
  • Burstein HJ; Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Greil R; GEICAM Spanish Breast Cancer Group, Madrid, Spain.
  • Fox P; Dana-Farber Cancer Institute, Boston, MA.
  • Wolff AC; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute-Center of Clinical Cancer and Immunology Trials; Cancer Cluster Salzburg, Salzburg, Aus
  • Chan A; Central West Cancer Care Centre, Orange Health Service, Orange, NSW, Australia.
  • Winer EP; Johns Hopkins University, Baltimore, MD.
  • Pfeiler G; Breast Cancer Research Centre-WA & Curtin University, Perth, Australia.
  • Miller KD; Dana-Farber Cancer Institute, Boston, MA.
  • Colleoni M; Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria.
  • Suga JM; Department of Gynecology and Gynecological Oncology, Medical University of Vienna, Vienna, Austria.
  • Rubovsky G; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN.
  • Bliss JM; IEO, European Institute of Oncology, IRCCS, Milan, Italy.
  • Mayer IA; Kaiser Permanente Vallejo Medical Center, Vallejo, CA.
  • Singer CF; National Institute of Oncology, Budapest, Hungary.
  • Nowecki Z; The Institute of Cancer Research, London, United Kingdom.
  • Hahn O; Vanderbilt University Medical Center, Nashville, TN.
  • Thomson J; Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria.
  • Wolmark N; Department of Gynecology and Gynecological Oncology, Medical University of Vienna, Vienna, Austria.
  • Amillano K; The Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
  • Rugo HS; University of Chicago, Chicago, IL.
  • Steger GG; Peninsula Health, Melbourne, Australia.
  • Hernando Fernández de Aránguiz B; NSABP Foundation, Inc, and The UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA.
  • Haddad TC; Hospital Universitari Sant Joan de Reus, Reus, Spain.
  • Perelló A; University of California San Francisco Comprehensive Cancer Center, San Francisco, CA.
  • Bellet M; Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria.
  • Fohler H; GEICAM Spanish Breast Cancer Group, Madrid, Spain.
  • Metzger Filho O; Hospital Universitario de Burgos, Burgos, Spain.
  • Jallitsch-Halper A; Mayo Clinic, Rochester, MN.
  • Solomon K; Hospital Universitari Son Espases, Palma de Mallorca, Spain.
  • Schurmans C; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Theall KP; ABCSG, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria.
  • Lu DR; GEICAM Spanish Breast Cancer Group, Madrid, Spain.
  • Tenner K; Alliance Foundation Trials, Boston, MA.
  • Fesl C; ABCSG, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria.
  • DeMichele A; Alliance Foundation Trials, Boston, MA.
  • Mayer EL; BIG, Brussels, Belgium.
J Clin Oncol ; 40(3): 282-293, 2022 01 20.
Article en En | MEDLINE | ID: mdl-34874182
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_breast_cancer Asunto principal: Piperazinas / Piridinas / Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Antineoplásicos Hormonales / Terapia Neoadyuvante / Inhibidores de Proteínas Quinasas Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: Austria
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_breast_cancer Asunto principal: Piperazinas / Piridinas / Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Antineoplásicos Hormonales / Terapia Neoadyuvante / Inhibidores de Proteínas Quinasas Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: Austria